What we're reading, August 26, 2016: the middle class is burdened with increasing healthcare costs; how much do voters need to know about presidential candidates' health; and honoring the end-of-life wishes of patients with dementia.
Even with healthcare spending growth slowing, middle class families are shouldering an increasing amount of healthcare costs. According to The Wall Street Journal, healthcare in the United States is becoming a story of 3 different Americas. While the rich can easily afford healthcare and the poor can access public assistance, middle-income families are struggling as they devote 8.9% of their spending to healthcare. As spending on healthcare rises for these households, they are cutting back sharply on discretionary categories like dining out and clothing.
Health has started to become a big topic for the 2016 presidential election as claims circulate about the personal health of the candidates. So how much of a right do voters have to know about the medical histories of presidential candidates? NPR discussed the topic with Rob Darling, MD, a former White House physician, who admitted that while voters have the right to know if there is an illness that could affect a person’s ability to lead, there are gray areas and not everything needs to be divulged. Darling gave the example of President Roosevelt, who kept many aspects of his health a secret during his presidency.
Honoring a patient’s end-of-life wishes may be importance, but doing so can be difficult if the patient has dementia. With neurological disorders, patients may not be able to think clearly or articulate their end-of-life care wishes, but a new project may help, reported STAT. The Conversation Project, along with the Institute for Healthcare Improvement, has released a guide for end-of-life conversations for families of Alzheimer’s and dementia patients. The guide even breaks down the conversation based on a person’s cognitive abilities.
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Pegcetacoplan for PNH More Cost-Effective Than Anti-C5 Monoclonal Antibodies
April 18th 2024A cost-utility analysis conducted from the perspective of the Italian health system found that pegcetacoplan was more effective and less costly than 2 complement 5 (C5) inhibitors for the treatment of paroxysmal nocturnal hemoglobinuria (PNH).
Read More
Many Patients With Psoriasis in Clinical Trials Experience Nocebo Effects, Study Finds
April 18th 2024Half of patients exposed to placebo in clinical trials experienced adverse events (AEs), which may be partially explainable by nocebo effects, according to a recent review and meta-analysis.
Read More
Low-Volume Hospitals Had Higher Reoperation Rate, Postoperative Complications in CRC
April 18th 2024Patients opting for elective colorectal surgery to address colorectal cancer (CRC) could have different rates of reoperation and postoperative complications based on the size of the hospital.
Read More